Clinical trial
Observational Study on the Safety and Tolerability of Gadobutrol (Gadovist) Among Filipino Patients
NCT00905879 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observational Study on the Safety and Tolerability of Gadobutrol (Gadovist) Among Filipino Patients
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2009
- Completion date
- January 31, 2011
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
magnetic resonance imaging